The present disclosure is directed to chewing gum bases, where mineral filler in the gum base formulation has been replaced with at least one chewing gum base filler component selected from water-insoluble polysaccharides and derivatives thereof, water-insoluble bamboo fibers, water-insoluble proteins, and combinations thereof. The chewing gum bases of the present disclosure are essentially free of mineral filler. Also disclosed are processes for producing the chewing gum bases. The processes of the present disclosure utilize the chewing gum base filler component as a replacement for mineral fillers during various production stages.

The present disclosure is directed to chewing gum bases, where mineral filler in the gum base formulation has been replaced with at least one chewing gum base filler component selected from water-insoluble polysaccharides and derivatives thereof, water-insoluble bamboo fibers, water-insoluble proteins, and combinations thereof. The chewing gum bases of the present disclosure are essentially free of mineral filler. Also disclosed are processes for producing the chewing gum bases. The processes of the present disclosure utilize the chewing gum base filler component as a replacement for mineral fillers during various production stages.

Compositions of chewing gum base that can include hydrocolloids and coupling agents are provided. Methods of making gum bases and chewing gum formulations are also provided.

Compositions of chewing gum base that can include hydrocolloids and coupling agents are provided. Methods of making gum bases and chewing gum formulations are also provided.

A chewing gum base which contains an edible Oil Elastomer prepared by reacting an epoxidized edible oil with a multifunctional acid.

A chewing gum base which contains an edible Oil Elastomer prepared by reacting an epoxidized edible oil with a multifunctional acid.

A composition and method for the use of Panax quinquefolius for the attenuation of Cannabis-induced dysphoria where dosage can be effectively administered in a gum base cold pressed into a tablet containing at least 300 mg of Panax quinquefolius and Maltitol, Sorbitol, Isomalt, Xylitol, natural & artificial flavors, vegetarian magnesium stearate, Sucralose and Silicon dioxide.

A composition and method for the use of Panax quinquefolius for the attenuation of Cannabis-induced dysphoria where dosage can be effectively administered in a gum base cold pressed into a tablet containing at least 300 mg of Panax quinquefolius and Maltitol, Sorbitol, Isomalt, Xylitol, natural & artificial flavors, vegetarian magnesium stearate, Sucralose and Silicon dioxide.

A gum base which, when formulated into a chewing gum, provides a gum base composition made with synthetic elastomers and elastomers plasticizers obtained from green or renewable and sustainable resources.

A gum base which, when formulated into a chewing gum, provides a gum base composition made with synthetic elastomers and elastomers plasticizers obtained from green or renewable and sustainable resources.